Status:
ENROLLING_BY_INVITATION
Reengineering Cervical Cancer Screening for the 21st Century: Joint Action for a Novel Up-to-date and Sustainable Screening Program
Lead Sponsor:
Instituto de Saude Publica da Universidade do Porto
Collaborating Sponsors:
Instituto Portugues de Oncologia, Francisco Gentil, Porto
Universidade do Porto
Conditions:
Cervical Cancer Screening
Eligibility:
FEMALE
30-69 years
Phase:
NA
Brief Summary
Cervical cancer screening (CCS) is important to prevent and control cervical cancer (CC). In Portugal, CCS starts with the assessment of the presence of Human Papillomavirus (HPV) in cervical-vaginal ...
Detailed Description
Vaccination against human papillomavirus (HPV) is highly effective and is expected to reduce substantially the burden of cervical cancer (CC), but cervical cancer screening (CCS) remains necessary for...
Eligibility Criteria
Inclusion
- Females fulfilling the eligibility criteria for CCS, as defined by the current guidelines for the organized screening program in Portugal.
Exclusion
- Not having a Portuguese mobile phone number or a Portuguese address available in the clinical/administrative records of the primary healthcare units;
- Any of the exclusion criteria for CCS, as defined by the current guidelines for the organized screening program in Portugal.
Key Trial Info
Start Date :
April 10 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2027
Estimated Enrollment :
5700 Patients enrolled
Trial Details
Trial ID
NCT06915610
Start Date
April 10 2025
End Date
March 31 2027
Last Update
April 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Unidade Local de Saúde Gaia e Espinho
Vila Nova de Gaia, Portugal, 4434-502